All Stories

  1. Cell wall melanin impedes growth of the Cryptococcus neoformans polysaccharide capsule by sequestering calcium
  2. The structure of a C. neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study
  3. The hypothermic nature of fungi
  4. Similar evolutionary trajectories in an environmental Cryptococcus neoformans isolate after human and murine infection
  5. Bet-hedging antimicrobial strategies in macrophage phagosome acidification drive the dynamics of Cryptococcus neoformans intracellular escape mechanisms
  6. On the relationship between Pathogenic Potential and Infective Inoculum
  7. Glyphosate inhibits melanization and increases susceptibility to infection in insects
  8. A glycan FRET assay for detection and characterization of catalytic antibodies to the Cryptococcus neoformans capsule
  9. Updating the fungal infection-mammalian selection hypothesis at the end of the Cretaceous Period
  10. The intracellular pathogen concept
  11. The Buoyancy ofCryptococcus neoformansIs Affected by Capsule Size
  12. The Capsule of Cryptococcus neoformans Modulates Phagosomal pH through Its Acid-Base Properties
  13. In Fungal Intracellular Pathogenesis, Form Determines Fate
  14. Opsonin-free, real-time imaging of Cryptococcus neoformans capsule during budding
  15. Analysis and Correction of Inappropriate Image Duplication: the Molecular and Cellular Biology Experience
  16. Extracellular vesicles and vesicle-free secretome of the protozoa Acanthamoeba castellanii under homeostasis and nutritional stress and their damaging potential to host cells
  17. Conservation of Intracellular Pathogenic Strategy among Distantly Related Cryptococcal Species
  18. Using Preprints for Journal Clubs
  19. The Capsule of Cryptococcus neoformans
  20. Graduate Biomedical Science Education Needs a New Philosophy
  21. Erratum for Schloss et al., “Support Science by Publishing in Scientific Society Journals”
  22. What Is a Host? Attributes of Individual Susceptibility
  23. Support Science by Publishing in Scientific Society Journals
  24. Antibody-Mediated Catalysis in Infection and Immunity
  25. The mBio American Academy of Microbiology Submission Track in 2017
  26. Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility
  27. Rigorous Science: a How-To Guide
  28. A Framework for Improving the Quality of Research in the Biological Sciences
  29. Moonshot Science—Risks and Benefits
  30. Reply to “Funding by Lottery: Political Problems and Research Opportunities”
  31. ASM Journals Eliminate Impact Factor Information from Journal Websites
  32. ASM Journals Eliminate Impact Factor Information from Journal Websites
  33. ASM Journals Eliminate Impact Factor Information from Journal Websites
  34. ASM Journals Eliminate Impact Factor Information from Journal Websites
  35. ASM Journals Eliminate Impact Factor Information from Journal Websites
  36. ASM Journals Eliminate Impact Factor Information from Journal Websites
  37. ASM Journals Eliminate Impact Factor Information from Journal Websites
  38. ASM Journals Eliminate Impact Factor Information from Journal Websites
  39. The Holobiont/Hologenome Concept Series
  40. Revolutionary Science
  41. Impacted Science: Impact Is Not Importance
  42. (A)Historical Science
  43. Field Science—the Nature and Utility of Scientific Fields
  44. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
  45. The Justification for the Academy Track in mBio
  46. Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research
  47. Role of Cln1 during melanization of Cryptococcus neoformans
  48. Dual-Use Research of Concern (DURC) Review at American Society for Microbiology Journals
  49. Achieving Speaker Gender Equity at the American Society for Microbiology General Meeting
  50. Biofilm Formation by Cryptococcus neoformans
  51. Competitive Science: Is Competition Ruining Science?
  52. Lipid Biosynthetic Genes Affect Candida albicans Extracellular Vesicle Morphology, Cargo, and Immunostimulatory Properties
  53. Lymphatic Aging
  54. The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases
  55. A New Synthesis for Dual Use Research of Concern
  56. Solid-state NMR Reveals the Carbon-based Molecular Architecture of Cryptococcus neoformans Fungal Eumelanins in the Cell Wall
  57. Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences
  58. The Importance of Virology at a Time of Great Need and Great Jeopardy
  59. Distribution and impact of yeast thermal tolerance permissive for mammalian infection
  60. Release of mycobacterial antigens
  61. B cells and antibodies in the defense againstMycobacterium tuberculosisinfection
  62. Competitive Science: Is Competition Ruining Science?
  63. Radiolabeled Antibodies for Therapy of Infectious Diseases
  64. What is infectiveness and how is it involved in infection and immunity?
  65. mBio Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
  66. Falling down the Rabbit Hole: aTRIP Toward Lexiconic Precision in the “Gain-of-Function” Debate
  67. Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
  68. Microbiology: Ditch the term pathogen
  69. Challenges posed by extracellular vesicles from eukaryotic microbes
  70. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection
  71. Compositional and immunobiological analyses of extracellular vesicles released byCandida albicans
  72. What Is a Host? Incorporating the Microbiota into the Damage-Response Framework: TABLE 1
  73. Acknowledgment of Invited Editors
  74. Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan
  75. Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy
  76. Financial costs and personal consequences of research misconduct resulting in retracted publications
  77. Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae
  78. A Role for LHC1 in Higher Order Structure and Complement Binding of the Cryptococcus neoformans Capsule
  79. Pathogenicity of Cryptococcus neoformans: an Evolutionary Perspective
  80. Pigment Production on L-Tryptophan Medium by Cryptococcus gattii and Cryptococcus neoformans
  81. Cryptococcus neoformans: Latency and Disease
  82. The History of Cryptococcus and Cryptococcosis
  83. Cryptococcosis
  84. Acquired Humoral Immunity to Cryptococcus neoformans
  85. Acquired Immunity against Fungi
  86. Vaccines and Antibody Therapies from Cryptococcus neoformans to Melanoma
  87. Melanin: Structure, Function, and Biosynthesis in Cryptococcus
  88. The Architecture and Antigenic Composition of the Polysaccharide Capsule
  89. Cryptococcus neoformans: Nonvertebrate Hosts and the Emergence of Virulence
  90. Acquired Antibody-Mediated Immunity to Fungi
  91. Specialized Science
  92. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct
  93. Platelet-activating Factor Contributes to Bacillus anthracis Lethal Toxin-associated Damage
  94. The Intracellular Life ofCryptococcus neoformans
  95. Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
  96. Demonstration of a common indole-based aromatic core in natural and synthetic eumelanins by solid-state NMR
  97. The Tools for Virulence of Cryptococcus neoformans
  98. Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria
  99. Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis
  100. Global structures of IgG isotypes expressing identical variable regions
  101. The constant region affects antigen binding of antibodies to DNA by altering secondary structure
  102. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis
  103. Phylogenetics and Evolution of Virulence in the Kingdom Fungi
  104. Radioimmunotherapy ofCryptococcus neoformansspares bystander mammalian cells
  105. Progress in understanding fungal pathogenesis
  106. Correction: Why Has the Number of Scientific Retractions Increased?
  107. Why Has the Number of Scientific Retractions Increased?
  108. Immunogenicity of mycobacterial vesicles in humans: Identification of a new tuberculosis antibody biomarker
  109. The Role of Host Gender in the Pathogenesis of Cryptococcus neoformans Infections
  110. Why We Cheat
  111. Allergen1regulates polysaccharide structure inCryptococcus neoformans
  112. Disease-Enhancing Antibodies Improve the Efficacy of Bacterial Toxin-Neutralizing Antibodies
  113. Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma
  114. Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development
  115. Exserohilum rostratum fungal meningitis associated with methylprednisolone injections
  116. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy
  117. The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients
  118. Elucidating the Structural Framework of Synthetic and Fungal Melanins by Solid-State NMR
  119. The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies
  120. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan
  121. Compton Scattering by Internal Shields Based on Melanin-Containing Mushrooms Provides Protection of Gastrointestinal Tract from Ionizing Radiation
  122. Fungi and the Rise of Mammals
  123. Using Solid-State NMR To Monitor the Molecular Consequences of Cryptococcus neoformans Melanization with Different Catecholamine Precursors
  124. Recent progress in vaccines against fungal diseases
  125. Winner Takes All
  126. Monoclonal Antibodies and Toxins—A Perspective on Function and Isotype
  127. Quorum sensing in fungi – a review
  128. Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases
  129. Mouse models for the study of fungal pneumonia
  130. The future of biological warfare
  131. Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication
  132. Strain-related differences in antibody-mediated changes in gene expression are associated with differences in capsule and location of binding
  133. Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles
  134. Fungal Melanins Differ in Planar Stacking Distances
  135. Adaptations of avian flu virus are a cause for concern
  136. Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells
  137. Reforming Science
  138. A Global Forum for Clinical Microbiologists and Immunologists
  139. Q&A: What is a pathogen? A question that begs the point
  140. Recent Advances on Model Hosts
  141. Probing the Molecular Architecture and Assembly of Synthetic and Fungal Melanins with Solid-State NMR
  142. In Vitro Measurement of Phagocytosis and Killing of Cryptococcus neoformans by Macrophages
  143. Reforming Science: Structural Reforms
  144. A new synthesis for antibody-mediated immunity
  145. Synthesis and assembly of fungal melanin
  146. Vesicular transport systems in fungi
  147. Protection of the Melanized Fungus Cryptococcus Neoformans From Lethal Dose Gamma Irradiation Involves Changes in Melanin's Chemical Structure and Paramagnetic Properties
  148. Methylxanthine Inhibit Fungal Chitinases and Exhibit Antifungal Activity
  149. Amoeba Provide Insight into the Origin of Virulence in Pathogenic Fungi
  150. Ten Challenges on Cryptococcus and Cryptococcosis
  151. Protection of Melanized Cryptococcus neoformans from Lethal Dose Gamma Irradiation Involves Changes in Melanin's Chemical Structure and Paramagnetism
  152. Cryptococcus neoformans Capsular Enlargement and Cellular Gigantism during Galleria mellonella Infection
  153. Gamma radiation interacts with melanin to alter its oxidation–reduction potential and results in electric current production
  154. Cryptococcus neoformansgalactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy
  155. Microbial Virulence as an Emergent Property: Consequences and Opportunities
  156. The effect of L-DOPA onCryptococcus neoformansgrowth and gene expression
  157. Phospholipids Trigger Cryptococcus neoformans Capsular Enlargement during Interactions with Amoebae and Macrophages
  158. Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence
  159. mBio’s First Birthday
  160. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice
  161. Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis
  162. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity
  163. Melanin and Resistance to Ionizing Radiation in Fungi
  164. Fungal Polysaccharides: Biological Activity Beyond the Usual Structural Properties
  165. Biophysical Methods for the Study of Microbial Surfaces
  166. Phenylalanine hydroxylase (PAH) from the lower eukaryote Leishmania major
  167. Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections
  168. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
  169. Melanin-Covered Nanoparticles for Protection of Bone Marrow During Radiation Therapy of Cancer
  170. Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6
  171. Cryptococcus
  172. Biogenesis of extracellular vesicles in yeast
  173. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule ofCryptococcus neoformans
  174. Reproducible Science
  175. Role of CD45 Signaling Pathway in Galactoxylomannan-Induced T Cell Damage
  176. An insight into the antifungal pipeline: selected new molecules and beyond
  177. Radioimmunotherapy Is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection
  178. Paramecium species ingest and kill the cells of the human pathogenic fungus Cryptococcus neoformans
  179. Proteasome Inhibitors Prevent Caspase-1-Mediated Disease in Rodents Challenged with Anthrax Lethal Toxin
  180. Intracellular cryptococci suppress Fc-mediated cyclin D1 elevation
  181. Correction: Fungal Cell Gigantism during Mammalian Infection
  182. Fungal Cell Gigantism during Mammalian Infection
  183. Characterization of Yeast Extracellular Vesicles: Evidence for the Participation of Different Pathways of Cellular Traffic in Vesicle Biogenesis
  184. Destruction of Microbial Collections in Response to Select Agent and Toxin List Regulations
  185. ASM Launches mBio
  186. Cryptococci at the brain gate: break and enter or use a Trojan horse?
  187. Abstract 5344: The contribution of unlabeled antibodies to intracellular antigens to efficacy of radioimmunotherapy in experimental metastatic melanoma and cervical cancer
  188. Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure☆
  189. Hark back: Passive immunotherapy for influenza and other serious infections
  190. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism
  191. The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of 188Re-labeled anti-E6 C1P5 antibody in cervical cancer in mice
  192. The use of chitosan to damage Cryptococcus neoformans biofilms
  193. Microbial threat lists: obstacles in the quest for biosecurity?
  194. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo
  195. Natural Melanin Produced in Fungi Protects Cells from High Dose Ionizing Radiation: An EPR Study
  196. Monoclonal antibody-based therapies for microbial diseases
  197. The still obscure attributes of cryptococcal glucuronoxylomannan
  198. Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan
  199. Vertebrate Endothermy Restricts Most Fungi as Potential Pathogens
  200. Physico-Chemical Evaluation of Rationally Designed Melanins as Novel Nature-Inspired Radioprotectors
  201. The “Nuclearization” of Biology Is a Threat to Health and Security
  202. The Elastic Properties of the Cryptococcus neoformans Capsule
  203. Virulence factors and their mechanisms of action: the view from a damage–response framework
  204. Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18
  205. The case for pathogen-specific therapy
  206. The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies
  207. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan
  208. Vesicular transport across the fungal cell wall
  209. Radioimmunotherapy of Infectious Diseases
  210. Sec6-dependent sorting of fungal extracellular exosomes and laccase ofCryptococcus neoformans
  211. Is Peer Review Censorship?
  212. The still obscure attributes of cryptococcal glucuronoxylomannan
  213. The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes
  214. Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans
  215. Intracellular pathogenic bacteria and fungi — a case of convergent evolution?
  216. Ionizing radiation: how fungi cope, adapt, and exploit with the help of melanin
  217. Biodefense Research: A Win-Win Challenge
  218. Evolution of Intracellular Pathogens
  219. Capsule enlargement inCryptococcus neoformansconfers resistance to oxidative stress suggesting a mechanism for intracellular survival
  220. In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxins
  221. The Outcome of Phagocytic Cell Division with Infectious Cargo Depends on Single Phagosome Formation
  222. Fungal killing by mammalian phagocytic cells
  223. Antibody action after phagocytosis promotesCryptococcus neoformansandCryptococcus gattiimacrophage exocytosis with biofilm-like microcolony formation
  224. Vesicular transport inHistoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes
  225. A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis
  226. Finite-Element Model of Interaction between Fungal Polysaccharide and Monoclonal Antibody in the Capsule of Cryptococcus neoformans
  227. Characterization of Phenotypic Switching in Cryptococcus neoformans Biofilms
  228. Following Fungal Melanin Biosynthesis with Solid-State NMR: Biopolymer Molecular Structures and Possible Connections to Cell-Wall Polysaccharides †
  229. Chemosorption of radiometals of interest to nuclear medicine by synthetic melanins
  230. The immunoglobulin constant region contributes to affinity and specificity
  231. Analysis of epitope information related toBacillus anthracisandClostridium botulinum
  232. Passive administration of monoclonal antibodies to Anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis
  233. Pulmonary cryptococcosis induces chitinase in the rat
  234. Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1
  235. The radioprotective properties of fungal melanin are a function of its chemical composition, stable radical presence and spatial arrangement
  236. Exchanging Murine and Human Immunoglobulin Constant Chains Affects the Kinetics and Thermodynamics of Antigen Binding and Chimeric Antibody Autoreactivity
  237. Determinants of virulence in the pathogenic fungi
  238. New insights on the pathogenesis of invasive Cryptococcus neoformans infection
  239. Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51
  240. Phage Display Library Derived Peptides that Bind to Human Tumor Melanin as Potential Vehicles for Targeted Radionuclide Therapy of Metastatic Melanoma
  241. Treating Cancer as an Infectious Disease—Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology
  242. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations
  243. Caspofungin reduces the incidence of fungal contamination in cell culture
  244. Fungal Infections (In Humans)
  245. Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches
  246. Targeting the Virus with Radioimmunotherapy in Virus-Associated Cancers
  247. Coccidioides posadasii produces melanin in vitro and during infection
  248. SEROLOGIC EVIDENCE FOR REGIONAL DIFFERENCES IN PEDIATRIC CRYPTOCOCCAL INFECTION
  249. Ionizing Radiation Changes the Electronic Properties of Melanin and Enhances the Growth of Melanized Fungi
  250. Targeting host cells harbouring viruses with radiolabeled antibodies
  251. The volume and hydration of the Cryptococcus neoformans polysaccharide capsule
  252. Cryptotrichosporon anacardii gen. nov., sp. nov., a new trichosporonoid capsulate basidiomycetous yeast from Nigeria that is able to form melanin on niger seed agar
  253. Pathogenesis of Cryptococcus neoformans
  254. Exploiting Amoeboid and Non-Vertebrate Animal Model Systems to Study the Virulence of Human Pathogenic Fungi
  255. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages
  256. DEVELOPING A MATHEMATICAL MODEL OF PHAGOCYTOSIS: A LEARNING PROCESS
  257. Update : Renaissance of Targeting Molecules for Melanoma
  258. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance
  259. Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins
  260. Phagosome Extrusion and Host-Cell Survival after Cryptococcus neoformans Phagocytosis by Macrophages
  261. The capsular dynamics of Cryptococcus neoformans
  262. Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis
  263. Immunomodulators as an antimicrobial tool
  264. Efficacy of voriconazole in experimental Cryptococcus neoformans infection
  265. Specific Antibody to Cryptococcus neoformans Glucurunoxylomannan Antagonizes Antifungal Drug Action against Cryptococcal Biofilms In Vitro
  266. Equatorial ring-like channels in the Cryptococcus neoformans polysaccharide capsule
  267. Interaction of Radiolabeled Antibodies with Fungal Cells and Components of the Immune System In Vitro and during Radioimmunotherapy for Experimental Fungal Infection
  268. Enhanced Allergic Inflammation and Airway Responsiveness in Rats with Chronic Cryptococcus neoformans Infection: Potential Role for Fungal Pulmonary Infection in the Pathogenesis of Asthma
  269. Radiolabeled Melanin-Binding Peptides Are Safe and Effective in Treatment of Human Pigmented Melanoma in a Mouse Model of Disease
  270. Structural and functional characterization of glycosylation in an immunoglobulin G1 to Cryptococcus neoformans glucuronoxylomannan
  271. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8
  272. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold1
  273. The weapon potential of human pathogenic fungi
  274. Polysaccharide-containing conjugate vaccines for fungal diseases
  275. A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens
  276. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding
  277. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility
  278. Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates
  279. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases
  280. The potential of antibody-mediated immunity in the defence against biological weapons
  281. Melanin as a potential target for radionuclide therapy of metastatic melanoma
  282. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures
  283. A point mutation in the Ch3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity
  284. Prof. Dr. Ricardo Arturo Ronderos (1928-1995)
  285. Microstructure of Cell Wall-Associated Melanin in the Human Pathogenic Fungus Cryptococcus neoformans †
  286. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection?
  287. Investigation of Fungal Deterioration of Synthetic Paint Binders Using Vibrational Spectroscopic Techniques
  288. Coping with Multiple Virulence Factors: Which Is Most Important?
  289. Role of Antibody-Mediated Immunity in Host Defense against Mycobacterium tuberculosis
  290. Prospects of vaccines for medically important fungi Feasibility and prospects for a vaccine to prevent cryptococcosis
  291. Glucuronoxylomannan, a Microbial Compound, Regulates Expression of Costimulatory Molecules and Production of Cytokines in Macrophages
  292. Blastomyces dermatitidis produces melanin in vitro and during infection
  293. Passive antibody therapy for infectious diseases
  294. The methodology for determining the efficacy of antibody-mediated immunity
  295. The weapon potential of a microbe
  296. Response to Fehr and Ochsenbein: ‘Good’, ‘bad’ and ‘neutral’ antibodies depend on the host–microbe interaction
  297. Experimental modulation of capsule size in Cryptococcus neoformans
  298. Cryptococcus neoformans var. gattii can exploit Acanthamoeba castellanii for growth
  299. Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India1
  300. A ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature
  301. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum
  302. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum
  303. The damage-response framework of microbial pathogenesis
  304. ‘Anti-virulence’ genes – further muddling the lexicon?
  305. Antibody-mediated regulation of cellular immunity and the inflammatory response
  306. Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response
  307. ‘Ready made’ virulence and ‘dual use’ virulence factors in pathogenic environmental fungi — the Cryptococcus neoformans paradigm
  308. Unlocking the Molecular Structure of Fungal Melanin Using 13 C Biosynthetic Labeling and Solid-State NMR †
  309. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3-mediated interactions
  310. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans
  311. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis
  312. Microbial virulence results from the interaction between host and microorganism
  313. The contribution of melanin to microbial pathogenesis
  314. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils
  315. Site-specific characterization of the N-linked oligosaccharides of a murine immunoglobulin M by high-performance liquid chromatography/electrospray mass spectrometry
  316. Cryptococcosis
  317. Phenotypic switching in Cryptococcus neoformans
  318. The meaning of microbial exposure, infection, colonisation, and disease in clinical practice
  319. Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons
  320. Induced humoral immunity and vaccination against major human fungal pathogens
  321. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformans
  322. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells
  323. Antibodies for defense against biological attack
  324. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity
  325. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection
  326. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection
  327. Adjunctive Immune Therapy for Fungal Infections
  328. Cryptococcus neoformans: intracellular or extracellular?
  329. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection
  330. Host‐Pathogen Interactions: The Attributes of Virulence
  331. Intracellular parasitism of macrophages by Cryptococcus neoformans
  332. Immunity to Fungi
  333. Fungal Infections in Humans
  334. Glyphosate Inhibits Melanization of Cryptococcus neoformans and Prolongs Survival of Mice after Systemic Infection
  335. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
  336. The Effect of the Echinocandin Analogue Caspofungin on Cell Wall Glucan Synthesis by Cryptococcus neoformans
  337. Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy
  338. Human and murine immunoglobulin expression vector cassettes
  339. Isolation and serological analyses of fungal melanins
  340. Host–microbe interactions: fungi
  341. Melanin and virulence in Cryptococcus neoformans
  342. Melanisation of Cryptococcus neoformans in human brain tissue
  343. Neutrophils from Patients with Advanced Human Immunodeficiency Virus Infection Have Impaired Complement Receptor Function and Preserved Fcγ Receptor Function
  344. Passive Antibody Therapies: Progress and Continuing Challenges
  345. Cryptococcus neoformans by Casadevall, Arturo & Perfect, John R. (1998) ASM Press, Washington, DC. Hardcover. 542 pp. $89.95. (ASM Member price: $79.95).
  346. Monoclonal Antibody–Mediated Toxicity in Cryptococcus neoformans Infection: Mechanism and Relationship to Antibody Isotype
  347. Labeling of Proteins with [35S]Methionine and/or [35S]Cysteine in the Absence of Cells
  348. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans
  349. Separated at Birth
  350. Serial Isolates of Cryptococcus neoformans from Patients with AIDS Differ in Virulence for Mice
  351. Cryptococcus neoformans
  352. Effect of Antibody to Capsular Polysaccharide on Eosinophilic Pneumonia in Murine Infection with Cryptococcus neoformans
  353. Effect of Immune Mechanisms on the Pharmacokinetics and Organ Distribution of Cryptococcal Polysaccharide
  354. Response from Casadevall
  355. Antibody-mediated protection against intracellular pathogens
  356. Antibody-based therapies as anti-infective agents
  357. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes
  358. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes
  359. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes
  360. Reply
  361. PERSISTENT VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM BACTEREMIA
  362. Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy
  363. Antibody-Based Therapies for Emerging Infectious Diseases
  364. Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?
  365. Pathology of cryptococcal meningoencephalitis: Analysis of 27 patients with pathogenetic implications
  366. Reply
  367. Reply
  368. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro
  369. Antibody immunity and Cryptococcus neoformans
  370. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody
  371. Decreased Fluconazole Susceptibility of a Relapse Cryptococcus neoformans Isolate After Fluconazole Treatment
  372. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans
  373. Cryptococcus neoformans infection can elicit protective antibodies in mice
  374. Enhancement of HIV Type 1 Infectivity in Vitro by Capsular Polysaccharide of Cryptococcus neoformans and Haemophilus influenzae
  375. Reactive Nitrogen Intermediates in Human Neuropathology: An Overview
  376. The Presence of Cryptococcal Capsular Polysaccharide Increases the Sensitivity of HIV-1 Coculture in Children
  377. MU switch region deletion is associated with both T cell independent and T cell dependent responses
  378. The reply
  379. Monoclonal antibody based ELISAs for cryptococcal polysaccharide
  380. Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS
  381. URA5 gene of Cryptococcus neoformans var. gattii: evidence for a close phylogenetic relationship between C. neoformans var. gattii and C. neoformans var. neoformans.
  382. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans
  383. Thermal difference circular dichroism of Pf1 filamentous virus and effects of mercury(II), silver(I), and copper(II)
  384. Raman spectroscopy of mercury(II) binding to two filamentous viruses: Ff (fd, M13, f1) and Pf1
  385. The precursor complex of Pf3 bacteriophage
  386. Silver and mercury probing of deoxyribonucleic acid structures in the filamentous viruses fd, If1, IKe, Xf, Pf1, and Pf3
  387. DNA packing in the filamentous viruses fd, Xf, Pfl and Pf3
  388. Notes and Queries
  389. Immunotherapy for Fungal Infections
  390. Antibody-Mediated Immunity to Fungi in the Lungs
  391. Carbohydrate-Based Antifungal Vaccines
  392. The Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases